Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Mross

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
Randomized phase II study of single-agent epirubicin +/- verapamil in patients with advanced metastatic breast cancer. An AIO clinical trial. Arbeitsgemeinschaft Internistische Onkologie of the German Cancer SocietyK Mross, C Bohn, L Edler, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1987
Absorption of epi-doxorubicin after intravesical administration in patients with in situ transitional cell carcinoma of the bladderK Mross, P Maessen, W J van der Vijgh, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1996
Fatal outcome of disseminated candidosis after allogeneic bone marrow transplantation under treatment with liposomal and conventional amphotericin-B. A report of 4 cases with determination of the Mic valuesW Krüger, I Sobottka, M Stockschläder, et al.
European Journal of Cancer (Oxford, England : 1990)|November 11, 2006
Results from an in vitro and a clinical/pharmacological phase I study with the combination irinotecan and sorafenibK Mross, S Steinbild, F Baas, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Pharmacokinetics and pharmacodynamics of the new podophyllotoxin derivative NK 611. A study by the AIO groups PHASE-I and APOHK Mross, A Hüttmann, K Herbst, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1996
Reverse transcriptase/polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patientsW Krüger, C Krzizanowski, M Holweg, et al.
British Journal of Cancer|June 2, 2005
Vinorelbine alternating oral and intravenous plus epirubicin in first-line therapy of metastatic breast cancer: results of a multicentre phase II studyD Serin, M Verrill, A Jones, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Dexverapamil to overcome epirubicin resistance in advanced breast cancerB Thürlimann, N Kröger, J Greiner, et al.
European Journal of Cancer (Oxford, England : 1990)|January 3, 2003
Altered clearance of unbound paclitaxel in elderly patients with metastatic breast cancerC H Smorenburg, A J ten Tije, J Verweij, et al.
Bone Marrow Transplantation|November 1, 1995
Bone marrow transplantation for Philadelphia-chromosome-positive acute lymphoblastic leukemiaM Stockschläder, S Hegewisch-Becker, W Krüger, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
Randomized phase II study of single-agent epirubicin +/- verapamil in patients with advanced metastatic breast cancer. An AIO clinical trial. Arbeitsgemeinschaft Internistische Onkologie of the German Cancer SocietyK Mross, C Bohn, L Edler, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1987
Absorption of epi-doxorubicin after intravesical administration in patients with in situ transitional cell carcinoma of the bladderK Mross, P Maessen, W J van der Vijgh, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1996
Fatal outcome of disseminated candidosis after allogeneic bone marrow transplantation under treatment with liposomal and conventional amphotericin-B. A report of 4 cases with determination of the Mic valuesW Krüger, I Sobottka, M Stockschläder, et al.
European Journal of Cancer (Oxford, England : 1990)|November 11, 2006
Results from an in vitro and a clinical/pharmacological phase I study with the combination irinotecan and sorafenibK Mross, S Steinbild, F Baas, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Pharmacokinetics and pharmacodynamics of the new podophyllotoxin derivative NK 611. A study by the AIO groups PHASE-I and APOHK Mross, A Hüttmann, K Herbst, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1996
Reverse transcriptase/polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patientsW Krüger, C Krzizanowski, M Holweg, et al.
British Journal of Cancer|June 2, 2005
Vinorelbine alternating oral and intravenous plus epirubicin in first-line therapy of metastatic breast cancer: results of a multicentre phase II studyD Serin, M Verrill, A Jones, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Dexverapamil to overcome epirubicin resistance in advanced breast cancerB Thürlimann, N Kröger, J Greiner, et al.
European Journal of Cancer (Oxford, England : 1990)|January 3, 2003
Altered clearance of unbound paclitaxel in elderly patients with metastatic breast cancerC H Smorenburg, A J ten Tije, J Verweij, et al.
Bone Marrow Transplantation|November 1, 1995
Bone marrow transplantation for Philadelphia-chromosome-positive acute lymphoblastic leukemiaM Stockschläder, S Hegewisch-Becker, W Krüger, et al.
Pageof 7